Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000231484, also known as the family with sequence similarity 182 member A pseudogene (FAM182A pseudogene) or AC023141.7, is classified as a pseudogene in the human genome and does not encode a functional protein. Pseudogenes arise from gene duplication or retrotransposition events, accumulating mutations that disrupt their coding potential, and generally do not serve as functional therapeutic targets. While most pseudogenes do not have protein-coding capability, some may produce non-coding RNAs that can regulate gene expression, but there is no evidence that this specific pseudogene has such functions. As a result, ENSG00000231484 is not considered a receptor, enzyme, transporter, or otherwise a direct drug target, nor is it associated with any known drug interactions, biomarker usage, or safety concerns.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 182 member A pseudogene (FAM182A pseudogene).